Exhibit 16.1
December 19, 2023
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read Item 4.01 of Form 8-K of Novelstem International Corp. dated December 19, 2023, and are in agreement with the statements contained therein.
Very truly yours,
/s/ Cherry Bekaert LLP